Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. [electronic resource]
Producer: 20190503Description: 1324-1332.e3 p. digitalISSN:- 1528-0012
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- adverse effects
- Clostridioides difficile -- drug effects
- Clostridium Infections -- diagnosis
- Denmark
- Fecal Microbiota Transplantation -- adverse effects
- Female
- Fidaxomicin -- adverse effects
- Humans
- Male
- Middle Aged
- Recurrence
- Remission Induction
- Time Factors
- Treatment Outcome
- Vancomycin -- adverse effects
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.